Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Fidia Spa ( (IT:FDA) ) has issued an update.
Fidia S.p.A. announced the conversion of five bonds into 200,000 new shares at a price of Euro 0.25 per share, as part of its convertible bond loan with GGHL. This conversion increases the company’s share capital by Euro 50,000, bringing the total number of shares to 12,852,385. The move is part of a larger capital increase strategy, with implications for the company’s market operations and shareholder value.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.50 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A. is a global leader in the design, production, and marketing of high-performance integrated milling systems, primarily serving the automotive and aerospace sectors. The company, listed on the Euronext Milan market, specializes in numerical controls for milling systems, high-speed milling systems, and CAM software for complex shapes, with over 40 years of experience and approximately 135 employees.
Average Trading Volume: 414,647
Technical Sentiment Signal: Strong Sell
Current Market Cap: €2.24M
See more data about FDA stock on TipRanks’ Stock Analysis page.